Jazz Pharma Plc (JAZZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,326,070 | 1,189,880 | 1,861,946 | 2,412,864 | 2,218,135 |
| Marketable Securities | 720,000 | 480,000 | 710,000 | 580,000 | 400,000 |
| Receivables | 764,364 | 714,004 | 652,992 | 716,765 | 723,639 |
| Inventories | 483,111 | 504,989 | 492,776 | 480,445 | 539,302 |
| Other current assets | 315,441 | 297,560 | 259,823 | 261,543 | 354,215 |
| TOTAL | $3,755,878 | $3,350,433 | $4,127,817 | $4,629,028 | $4,390,423 |
| Non-Current Assets | |||||
| PPE Net | 188,913 | 184,975 | 178,869 | 173,413 | 176,422 |
| Intangibles | 6,393,220 | 6,612,961 | 6,478,203 | 6,472,018 | 6,948,863 |
| Other Non-Current Assets | 1,018,474 | 795,772 | 749,794 | 737,798 | 740,007 |
| TOTAL | $7,600,607 | $7,593,708 | $7,406,866 | $7,383,229 | $7,865,292 |
| Total Assets | $11,356,490 | $10,944,140 | $11,534,680 | $12,012,260 | $12,255,720 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,029,179 | 1,028,478 | 31,000 | 31,000 | 31,000 |
| Accounts payable and accrued liabilities | 152,227 | 89,366 | 95,930 | 77,869 | 85,425 |
| Accrued Expenses | 1,001,556 | 874,811 | 1,063,918 | 910,947 | 858,578 |
| TOTAL | $2,274,102 | $2,071,205 | $1,222,610 | $1,038,573 | $1,029,977 |
| Non-Current Liabilities | |||||
| Long Term Debt | 4,331,982 | 4,335,616 | 5,336,481 | 6,077,640 | 6,080,802 |
| Other Non-Current Liabilities | 162,338 | 148,838 | 129,899 | 125,552 | 182,086 |
| TOTAL | $5,123,353 | $5,166,577 | $6,137,181 | $6,879,928 | $7,054,672 |
| Total Liabilities | $7,397,455 | $7,237,781 | $7,359,789 | $7,918,504 | $8,084,649 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 60,765 | 60,659 | 61,633 | 60,732 | 60,455 |
| Common Shares | 61 | 61 | 61 | 61 | 61 |
| Retained earnings | 443,198 | 191,786 | 1,035,279 | 1,127,820 | 936,705 |
| Other shareholders' equity | -569,898 | -485,768 | -785,610 | -947,667 | -603,397 |
| TOTAL | $3,959,030 | $3,706,359 | $4,174,891 | $4,093,756 | $4,171,067 |
| Total Liabilities And Equity | $11,356,485 | $10,944,140 | $11,534,680 | $12,012,260 | $12,255,716 |